Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Patiromer (Primary)
- Indications Hyperkalaemia
- Focus Therapeutic Use
- Acronyms REDUCE
- 17 Jan 2018 Status changed from recruiting to completed.
- 05 May 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2016.
- 18 Oct 2016 New trial record